Beam Therapeutics Stock Forecast
| Recent Beam Therapeutics Stock Price | Beam Therapeutics Stock Forecast Price | |
| $33.45 |  +104.66% |
$68.46 |
| Recent Beam Therapeutics Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 10 | 10 | 10 | 10 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 4 | 3 | 3 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.57 | 1.46 | 1.46 | 1.33 |
The presented Beam Therapeutics stock forecast (traded under symbol BEAM), for forward-twelve-months price target as shown at the top of this page, gives you the average Beam Therapeutics stock forecast for forward target price for symbol BEAM, across the 13 analysts covering Beam Therapeutics (BEAM), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Beam Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Beam Therapeutics stock forecast and half had a lower Beam Therapeutics stock forecast) was $66.0 as of 2023-06-09 (which is a different mathematical metric versus taking the average or mean), while the
highest Beam Therapeutics stock forecast in the analyst group was $105.0, and the lowest Beam Therapeutics stock forecast in the analyst group was
$37.0, with a standard deviation of $20.077. Get the latest Zacks research report on BEAM — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
|||||||||||||||||||||
|
|
|
 Free BEAM Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.43 out of 4) 53rd percentile
(ranked higher than approx. 53% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
